Entero Therapeutics Inc (ENTO)
0.4597
-0.17
(-27.03%)
USD |
NASDAQ |
Nov 14, 12:59
Entero Therapeutics Total Assets (Quarterly): 86.29M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 86.29M |
| March 31, 2024 | 91.13M |
| December 31, 2023 | 6.883M |
| September 30, 2023 | 5.927M |
| June 30, 2023 | 4.328M |
| March 31, 2023 | 5.534M |
| December 31, 2022 | 5.440M |
| September 30, 2022 | 4.645M |
| June 30, 2022 | 3.927M |
| March 31, 2022 | 8.825M |
| December 31, 2021 | 11.79M |
| September 30, 2021 | 12.42M |
| June 30, 2021 | 13.78M |
| March 31, 2021 | 17.98M |
| December 31, 2020 | 12.92M |
| September 30, 2020 | 16.72M |
| June 30, 2020 | 6.862M |
| March 31, 2020 | 8.184M |
| Date | Value |
|---|---|
| December 31, 2019 | 8.903M |
| September 30, 2019 | 9.436M |
| June 30, 2019 | 9.612M |
| March 31, 2019 | 8.956M |
| December 31, 2018 | 7.469M |
| September 30, 2018 | 8.578M |
| June 30, 2018 | 11.74M |
| March 31, 2018 | 5.248M |
| December 31, 2017 | 5.480M |
| September 30, 2017 | 6.836M |
| June 30, 2017 | 8.764M |
| March 31, 2017 | 5.424M |
| December 31, 2016 | 6.754M |
| September 30, 2016 | 5.586M |
| June 30, 2016 | 6.577M |
| March 31, 2016 | 6.309M |
| December 31, 2015 | 6.686M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
3.927M
Minimum
Jun 2022
91.13M
Maximum
Mar 2024
17.50M
Average
8.825M
Median
Mar 2022
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 3.925M |
| Palatin Technologies Inc | 10.74M |
| iBio Inc | 28.73M |
| Theriva Biologics Inc | 42.39M |
| Oragenics Inc | 2.710M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 15.49M |
| Shareholders Equity (Quarterly) | 70.80M |